The effect of deep brain stimulation randomized by site on balance in Parkinson's disease

Movement Disorders

Volumn 29, Issue 7, 2014, Pages 949-953

  St George, Rebecca J ^a   Carlson Kuhta, Patricia ^a   Nutt, John G ^a   Hogarth, Penelope ^a   Burchiel, Kim J ^a   Horak, Fay B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Clinical assessment; DBS; Parkinson's disease; Postural control

Indexed keywords

LEVODOPA;

ACTIVITIES OF DAILY LIVING QUESTIONNAIRE; ACTIVITIES SPECIFIC BALANCE CONFIDENCE SCALE; ADULT; ARTICLE; BALANCE AND GAIT SCALE; BALANCE IMPAIRMENT; BODY EQUILIBRIUM; BODY MOVEMENT; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; GAIT; GAIT DISORDER; GLOBUS PALLIDUS; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARKINSON DISEASE; PHYSICAL PERFORMANCE; POSTOPERATIVE PERIOD; POSTURAL INSTABILITY AND GAIT DISABILITY SCORE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SELF REPORT; THERAPY EFFECT; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; GAIT; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSTURAL BALANCE; TREATMENT OUTCOME;

EID: 84902240409     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25831     Document Type: Article

References (27)

1. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. Florham Park, NJ: Macmillan Healthcare Information; 1987.
2. Bakker M, Esselink RA, Munneke M, Limousin-Dowsey P, Speelman HD, Bloem BR. Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease. Mov Disord 2004;19:1092-1099.
3. Mancini M, Rocchi L, Horak F, Chiari L. Effects of Parkinson's disease and levodopa on functional limits of stability. Clin Biomech 2008;23:450-458.
4. Chong RK, Horak FB, Woollacott MH.Parkinson's disease impairs the ability to change set quickly. 2000;175:57-70.
5. Brown P, Marsden CD. What do the basal ganglia do? Lancet 1998;351:1801-1804.
6. Bloem BR, Hausdorff JM, Visser JE, et al. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 2004;19:871-884.
7. Cowie D, Limousin P, Peters A, Hariz M, Day BL. Doorway-provoked freezing of gait in Parkinson's disease. Mov Disord 2012;27:492-499.
8. Buchthal F, Fernandez-Ballesteros ML. Electromyographic study of the muscles of the upper arm and shoulder during walking in patients with Parkinson's disease. Brain 1965;88:875-896.
9. Zampieri C, Salarian A, Carlson-Kuhta P, Aminian K, Nutt JG, Horak FB. The instrumented Timed Up and Go test: potential outcome measure for disease modifying therapies in Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:171-176.
10. Rochester L, Hetherington V, Jones D, et al. Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil 2004;85:1578-1585.
11. Frank JS, Horak FB, Nutt J. Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 2000;84:2440-2448.
12. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci 1995;50A:M28-M34.
13. Schieppati M, Tacchini E, Nardone A, Tarantola J, Corna S. Subjective perception of body sway. J Neurol Neurosurg Psychiatry 1999;66:313-322.
14. Mak MK, Pang MY, Mak MKY, Pang MYC. Balance self-efficacy determines walking capacity in people with Parkinson's disease. Mov Disord 2008;23:1936-1939.
15. Mak MK, Pang MY, Mak MKY, Pang MYC. Balance confidence and functional mobility are independently associated with falls in people with Parkinson's disease. J Neurol 2009;256:742-749.
16. Rasovska H, Rektorova I. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study. J Neurol Sci 2011;310:279-282.
17. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol 2001;248:950-958.
18. St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg 2012;116:1347-1356.
19. West B, Welch K, Galecki A. Linear Mixed Models: A Practical Guide Using Statistical Software. Boca Raton, FL: Taylor & Francis Group; 2007.
20. Follett K, Weaver F, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
21. Sudhyadhom A, Bova FJ, Foote KD, et al. Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep 2007;7:278-289.
22. Odekerken V, van Laar T, Staal M, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
23. Jacobs JV, Horak FB. Cortical control of postural responses. J Neural Transm 2007;114:1339-1348.
24. Shivitz N, Koop MM, Fahimi J, et al. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not. Mov Disord 2006;21:1088-1097.
25. Rocchi L, Chiari L, Horak FB. Effect of levodopa and DBS on anticipatory postural adjustments in subjects with Parkinson's disease. Mov Disord 2004;19:S187-S188.
26. Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg 2012;117:1141-1149.
27. Nutt JG, Burchiel KJ, Comella CL, et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003;60:69-73.